11. OP0177 N-glycosylation sites in the variable domain of b cell receptors specific for citrullinated antigens. (15th June 2017) Authors: Slot, LM; Vergroesen, RD; Hafkenscheid, L; Koning, MT; Rispens, T; Veelken, H; Toes, RE; Scherer, HU Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. P648 Clinical feasibility of dried blood sampling for infliximab in IBD patients. (16th January 2018) Authors: Berends, S; D'Haens, G; Bloem, K; Schaap, J; De Vries, A; Rispens, T; Mathôt, R Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. P724 Unchanged infliximab serum concentrations after switching from the originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease: Results from a prospective study (SECURE). (16th January 2018) Authors: Strik, A; van de Vrie, W; Bloemsaat-Minekus, J; Nurmohamed, M; Bossuyt, P; Bodelier, A; Rispens, T; van Megen, Y; D'Haens, G Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort. (4th March 2023) Authors: van Ouwerkerk, L; van der Woude, D; Rispens, T; Allaart, CF; Huizinga, TWJ Journal: Scandinavian journal of rheumatology Issue: Volume 52:Number 2(2023) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Response to: 'The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region' by Rinaudo-Gaujous et al. Issue 8 (8th April 2015) Authors: van Schie, K A; Hart, M H; de Groot, E R; Kruithof, S; Aarden, L A; Wolbink, G J; Rispens, T Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 8(2015) Page Start: e41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. SAT0433 Anti-tnf treatment in rheumatoid arthritis and ankylosing spondylitis patients is associated with a strong increase of palmoplantar pustulosis but not of psoriasis vulgaris. (15th June 2017) Authors: Ruwaard, J; Vlugt, E van der; Nurmohamed, M; Rispens, T; Wolbink, GJ Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 935 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Search for a concentration–effect curve of adalimumab in ankylosing spondylitis patients. (3rd July 2016) Authors: Marsman, AF; Kneepkens, EL; Ruwaard, J; Wei, JC; Nurmohamed, MT; van Denderen, C; van der Horst-Bruinsma, IE; Rispens, T; Wolbink, G Journal: Scandinavian journal of rheumatology Issue: Volume 45:Number 4(2016) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis. (4th July 2019) Authors: l' Ami, MJ; Ruwaard, J; Krieckaert, CLM; Nurmohamed, MT; van Vollenhoven, RF; Rispens, T; Wolbink, GJ Journal: Scandinavian journal of rheumatology Issue: Volume 48:Number 4(2019) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study. (4th March 2017) Authors: Kneepkens, EL; van den Oever, IAM; Plasencia, CH; Pascual-Salcedo, D; de Vries, A; Hart, M; Nurmohamed, MT; Balsa, A; Rispens, T; Wolbink, G Journal: Scandinavian journal of rheumatology Issue: Volume 46:Number 2(2017) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region. Issue 1 (23rd October 2014) Authors: van Schie, K A; Hart, M H; de Groot, E R; Kruithof, S; Aarden, L A; Wolbink, G J; Rispens, T Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 1(2015) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗